Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The revision indicator on the page updated from v3.5.4 to v3.5.5, signaling a minor update to the version history rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-06-05T10:27:44.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This change reflects a backend update rather than a user-facing modification.
    Difference
    0.1%
    Check dated 2026-05-14T22:35:32.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a new site revision tag (v3.5.3) replacing the previous revision (v3.5.2), indicating a small platform update without changes to the study data or presentation.
    Difference
    0.1%
    Check dated 2026-04-30T18:22:10.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added. Revision: v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:09:28.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:13:05.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3; core study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:35.000Z thumbnail image

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.